德克薩斯州 的 脊髓性肌肉萎縮症 臨床試驗
10 項針對 脊髓性肌肉萎縮症 的研究正在 德克薩斯州 各地點尋找參與者。
德克薩斯州 的城市
官方研究文本（英文）
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
- The University of Texas Southwestern Medical Center at Dallas, Dallas
- Cook Children's Jane and John Justin Neurosciences Center, Fort Worth
招募中4 期
3 Months – 24 Months · 所有性別 · 更新於 2026年10月2日 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- University of Texas Southwestern Medical Center, Dallas
- Neurology Rare Disease Center, Flower Mound
- Cook Children's Medical Center, Fort Worth
- 還有 1 項
招募中2 期
2 歲以下 · 所有性別 · 更新於 2026年10月2日 · NCT07047144A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Neurology Rare Disease Center, Flower Mound
- Texas Children's Hospital, Houston
招募中2 期
5 至 17 歲 · 所有性別 · 更新於 2026年9月14日 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
- University of Texas Southwestern Medical Center, Dallas
招募中4 期
3 Months – 24 Months · 所有性別 · 更新於 2026年9月10日 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Texas Childrens Hospital Houston, Houston
招募中1 期
3 歲及以上 · 所有性別 · 更新於 2026年9月3日 · NCT06555419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Texas Children's Hospital, Houston
招募中
3 歲及以上 · 所有性別 · 更新於 2026年8月19日 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Neurology Rare Disease Center, Flower Mound
招募中3 期
0 Days – 42 Days · 所有性別 · 更新於 2026年8月18日 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Neurology Rare Disease Center, Flower Mound
招募中3 期
0 Days – 7 Months · 所有性別 · 更新於 2026年8月11日 · NCT07444450Clinical Procedures to Support Research in ALS
- University of Texas San Antonio Health Science Center, San Antonio
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年6月15日 · NCT03489278Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Cook Children's, Fort Worth
- Texas Children's Hospital, Houston
- CHRISTUS Health, San Antonio
招募中觀察性研究
所有年齡 · 所有性別 · 更新於 2025年1月31日 · NCT04174157資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。